Showing results (121-130 of 278) with videos related to

Sort By:
Pageof 28
Stereotactic and Functional Neurosurgery|January 29, 2024
Brain Shift during Staged Deep Brain Stimulation for Movement DisordersKeanu Chee, Lisa Hirt, Madelyn Mendlen, et al.
Brain Sciences|June 26, 2026
Theta Oscillations, Oculomotor Processing, and Neural Synchronization: A ReviewChiagoziem Anigbogu, Matthew N Svalina, Gavin R Hoffman, et al.
Targeted Oncology|July 26, 2020
Untangling the Multidisciplinary Care Web: Streamlining Care Through an Immune-Related Adverse Events (IRAE) Tumor BoardLaura C Kennedy, Kit Man Wong, Nikhil V Kamat, et al.
Frontiers in Psychiatry|December 11, 2023
Case report: Clinical efficacy of deep brain stimulation contacts corresponds to local field potential signals in a patient with obsessive-compulsive disorderKorrina A Duffy, Elizabeth A Fenstermacher, John A Thompson, et al.
Nutrition and Cancer|November 7, 2013
Procyanidin B2 3,3(″)-di-O-gallate, a biologically active constituent of grape seed extract, induces apoptosis in human prostate cancer cells via targeting NF-κB, Stat3, and AP1 transcription factorsAlpna Tyagi, Komal Raina, Suraj Prakash Shrestha, et al.
Cancer Immunology, Immunotherapy : CII|October 18, 2008
Immune activation in advanced cancer patients treated with recombinant IL-21: multianalyte profiling of serum proteinsMichael G Dodds, Klaus Stensgaard Frederiksen, Kresten Skak, et al.
Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine|June 23, 2009
Antibacterial properties of an iron-based hemostatic agent in vitro and in a rat wound modelDavid O Bracho, Lauren Barsan, Subramanyeswara R Arekapudi, et al.
Movement Disorders Clinical Practice|June 19, 2023
Comparison of Monopolar Review to Fixed Parameter Fractionation in Deep Brain StimulationJohn A Thompson, Lisa Hirt, Pamela David-Gerecht, et al.
The Oncologist|December 8, 2020
A Randomized Phase II Study of AGS-16C3F Versus Axitinib in Previously Treated Patients with Metastatic Renal Cell CarcinomaChristian Kollmannsberger, Toni K Choueiri, Daniel Y C Heng, et al.
Cancer|October 13, 2007
Evaluation of interferon alpha-2B and thalidomide in patients with disseminated malignant melanoma, phase 2, SWOG 0026Laura F Hutchins, James Moon, Joseph I Clark, et al.
Pageof 28